Scott Bergman, D.C., CTN, DAAIM
Advisory Board Member
Via XX Settembre, 12/2E - 16121
GENOVA (GE), ITALIA P.I 02140480993
GENOVA (GE), ITALIA P.I 02140480993
(+39) 3271180483
FOLLOW US
HEALTH CARE PROVIDERS
Health Care Providers interested in authorizing ProLon® for their patients can Register on the their national ProLon® website.
DISCLAIMER
The statements on this site have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
PEOPLE AFFECTED BY DIABETES
WARNING RELATED TO OUR RECENT STUDIES ON DIABETES: DO NOT TRY TO APPLY ANY TYPE OF FASTING MIMICKING DIET TO TREAT EITHER TYPE 1 OR TYPE 2 DIABETES ALONE OR EVEN WITH THE HELP OF A DOCTOR. THE COMBINATION OF THE FMD AND INSULIN BUT ALSO OTHER DRUGS COULD CAUSE SEVERE PROBLEMS. ALTHOUGH THE USE OF THE FMD TO TREAT EITHER TYPE 1 OR 2 DIABETES IS PROMISING, IT MUST BE FIRST TESTED AND PROVEN EFFECTIVE IN FDA CLINICAL TRIALS WHICH WILL PROBABLY REQUIRE HOSPITALIZATION DURING THE TREATMENT.
